Mosaic ImmunoEngineering, Inc. (CPMV)
OTCMKTS
· Delayed Price · Currency is USD
0.5400
+0.0283 (5.53%)
May 20, 2025, 4:00 PM EDT
Mosaic ImmunoEngineering Market Cap
Mosaic ImmunoEngineering has a market cap or net worth of $3.91 million as of May 22, 2025. Its market cap has decreased by -57.48% in one year.
Market Cap
3.91M
Enterprise Value
5.39M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.54
Market Cap Chart
Since October 15, 2020, Mosaic ImmunoEngineering's market cap has increased from 1.69M to 3.91M, an increase of 131.98%. That is a compound annual growth rate of 20.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 3.91M | -22.99% |
| Dec 31, 2024 | 5.08M | 16.87% |
| Dec 29, 2023 | 4.35M | -39.39% |
| Dec 30, 2022 | 7.17M | -2.75% |
| Dec 31, 2021 | 7.37M | 181.52% |
| Dec 31, 2020 | 2.62M | 55.34% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.63B |
| Veradigm | 747.23M |
| Nika Pharmaceuticals | 672.83M |
| Tian'an Technology Group | 591.73M |
| Elite Pharmaceuticals | 544.82M |
| CytoDyn | 485.22M |
| Glass House Brands | 477.46M |
| Northwest Biotherapeutics | 416.49M |